Europe PMC requires Javascript to function effectively.
Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.
Progression free survival (A) and overall survival (B) among patients in the AT population treated with alvocidib.